Gyre Therapeutics, Inc. GYRE Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s gross margin?
- Gyre Therapeutics, Inc. (GYRE) reported gross margin of 95.1% in Q1 2026.
- How has Gyre Therapeutics, Inc.'s gross margin changed year-over-year?
- Gyre Therapeutics, Inc.'s gross margin decreased by 1.2% year-over-year, from 96.2% to 95.1%.
- What is the long-term trend for Gyre Therapeutics, Inc.'s gross margin?
- Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s gross margin has grown at a -0.3% compound annual growth rate (CAGR), from 95.9% to 95.4%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.